How mRNA technology is creating affordable, potent vaccine products

We took the time to speak with Amy Walker, VP of research, at biotechnology company 4basebio to discuss if synthetic DNA templates represent the future of mRNA production.

Related Keywords

United Kingdom , ,Melinda Gates Foundation ,Innovate United Kingdom ,Transforming Medicine Manufacturing ,Bio Developments ,Pipelines ,Rna ,Rna Capabilities ,Vaccine ,